脑心通胶囊治疗椎-基底动脉供血不足性眩晕168例临床观察

The Effect 168 Cases of Verapamil Hydrochloride Sustained-Release Tablets in the Treatment of Vertebral-basilar Artery Insufficiency Vertigo

目的观察脑、心通肢囊治疗椎－基底动脉供血不足性眩晕的临床疗效。方法选取因椎－基底动脉供血不足性眩晕来我院住院治疗的患者168例．随机分为治疗组84例，给予脑心通胶囊口服，1挺3粒、3次／d，4周一个疗程。对照组84例，给予颈复康颗粒、山莨菪碱片厦颈部理疗等综合常规治疗。结果脑心通胶囊治疗椎－基底动脉供血不足性眩晕的总有效率为89.3％，两者差异有统计学意义（P〉0．05）。结论脑心通胶囊治疗椎－基底动脉供血不足性眩晕的疗效优于常规治疗。

Objective To study Verapamil Hydrochloride Sustained-Release Tablets in the treatment of vertabral-basilar artery insufficiency vertigo clinical curative effect. Methods Selection for vertebral-basilar artery insufficiency vertigo to the inpatients of our hospital in 168 patients which randomly divided into the treatment group 84 cases were given Verapamil Hydmchloride Sustained-Re｜ease Tablets orally, 3 tablets, 3 times/day, 4 Monday coumes. 84 cases in control group were given JingfukangKeli, Racanisodamine Tablets and neck physical comprehensive conventional therapy. Results Effect of Verapamil Hydrochloride Sustained-Release Tablets in the treatment of vertabral-basilar artery insufficiency vertigo in the total efficiency was 89.3%, the difference was statistically significant （P〉0.05）. Coneulsion The treatment effect of vertebral-basilar artery insufficiency vertigo with Verapamil Hydrochloride Sustained-Release Tablets is superior to conventional therapy.